Nanoparticles developed to target and eliminate brain cancer cells in mice

Scientists have engineered smart nanoparticles capable of both illuminating glioblastoma cells during surgery and destroying remaining microscopic cancer cells. In mouse models, this innovative approach successfully prevented recurrence, leading to 100% survival over 60 days. This development offers a promising new strategy for treating aggressive brain tumors, though human trials are still pending.